Cancer HorizonsAll NewsBlogsCaregivingDiet and ExerciseFinancialPsychosocialRecipesSexual HealthSide EffectSponsoredSurvivorship
All VideosCURE ConnectionsCURE Expert Connections®CURE Speaking OutCURE TVEducated Patient Sound BitesOn Demand: Webinars
Conference Coverage Conference Listing
CURE AdventuresCURE AwardsEducated Patient In Person EducationEducated Patient Virtual Education
Advocacy GroupsArt GalleryClinical Trial CornerHeal®PartnersPodcastsPublicationsShare Your Story
Subscribe
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
Spotlight -
  • Blogs
  • Breast Cancer Webinar Series
  • Cancer Horizons
  • Clinical Trial Corner
  • Heal®
  • Publications
  • Videos
Blood CancersBlood CancersBlood CancersBlood Cancers
Brain Cancer
Breast CancerBreast Cancer
Childhood Cancers
Gastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal CancersGastrointestinal Cancers
Genitourinary CancersGenitourinary CancersGenitourinary CancersGenitourinary Cancers
Gynecologic CancerGynecologic CancerGynecologic Cancer
Head & Neck Cancer
LeukemiaLeukemiaLeukemia
Lung Cancer
LymphomaLymphomaLymphomaLymphoma
Rare CancersRare Cancers
Sarcoma
Skin Cancer/Melanoma
Thyroid Cancer
    • Subscribe
Advertisement

Article

May 25, 2018

Half of Five-Year Survivors of Breast Cancer Are Not Receiving Recommended Post-Surgery Mammograms

Author(s):

Brielle Benyon

NCCN guidelines recommend annual mammograms to detect disease recurrence, but according to the study’s findings, women — even those who had adequate health insurance — were less likely to have their once-a-year mammogram as they became long-term survivors.

While awareness continues to spread about regular mammograms to detect breast cancer, a recent study published in the Journal of the National Comprehensive Cancer Network (NCCN) found that many breast cancer survivors are not getting the proper level of screening after they have surgery for the disease.

NCCN guidelines recommend annual mammograms to detect disease recurrence, but according to the study’s findings, women — even those who had adequate health insurance — were less likely to have their once-a-year mammogram as they became long-term survivors.

“This lack of imaging follow-up represents a missed opportunity for identifying recurrent or new breast cancers among a high-risk patient subgroup,” Benjamin O. Anderson, M.D., FACS, vice chair of the NCCN Guidelines Panel for Breast Cancer, said in a statement. Anderson is professor of surgery and global health medicine at the University of Washington and Fred Hutchinson Cancer Research Center.

“Of equal importance, this finding illustrates that our health care system can fail to track sizable groups of cancer patients after completion of treatment,” he said. “The NCCN guidelines for survivorship delineate the quality-of-life issues that patients must address, which together with tests like follow-up mammograms should be a coherent and integrated survivorship plan.”

In the retrospective study, more than 27,000 patients were followed for a median 2.9 years after breast cancer surgery. The study excluded those who underwent bilateral mastectomies, since they do not need mammograms. After 65 months, 4,790 patients remained in the study cohort.

One year after cancer surgery, 13 percent of women did not undergo any breast imaging. As time went on, that number continued to increase. Five years after surgery, 19 percent of women went the year without imaging. In total, only 50 percent of the patients who were followed for five or more years had at least one mammogram per year.

The researchers on the study also found that African-American survivors were less likely than Caucasian survivors to get their yearly mammograms. This is particularly a point of interest since black women die of breast cancer at a higher rate than white women, and recurrence is a major driver for this.

According to the American Cancer Society, between the years 2009 and 2013, for every 100,000 people, 29.6 African-Americans died of the disease, compared to an average of 21 people per 100,000 in Caucasians. Limited access by black women to genetic testing could be a factor, according to the NCCN, but further research is needed to better understand why this disparity exists.

“The use of regular mammograms to detect a return of breast cancer before any symptoms appear is associated with better overall survival,” said Kathryn Ruddy, M.D., M.P.H., director of cancer survivorship for the Department of Oncology at the Mayo Clinic Cancer Center, in a release.

Ruddy was the lead author on the study and a member of the NCCN Clinical Practice Guidelines in Oncology Panel for Survivorship.

“Therefore, clinicians need to make sure that their patients are fully aware of the role these annual mammograms play in screening for new breast cancers as well as for local recurrences. Creating and implementing survivorship care plans with clear follow-up instructions may help ensure that more survivors adhere to recommended screening schedules,” she said.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Image of two doctors with text.
Imiage of two doctors with text.
Enhertu with Perjeta nearly doubled progression-free survival versus standard treatment in metastatic HER2-positive breast cancer, study shows.
Dr. Massimo Cristofanilli discusses the early use of camizestrant with a CDK4/6 inhibitor to target ESR1 mutations, as it may improve outcomes in metastatic breast cancer.
Image of woman.
Picture of Dr. Pouneh Razavi
Image of a woman wearing a headband and glasses
Image of doctor.
Image of woman.
Related Content
Advertisement
Image of women with text.
June 25th 2025

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy: © stock.adobe.com.
June 24th 2025

How a Blood Test May Help Guide Breast Cancer Treatment

Ryan Scott
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
After my breast cancer diagnosis, faith guided me through fear: © stock.adobe.com.
June 23rd 2025

Faith, Friendship and Finding Purpose After Breast Cancer

Shirley Rakuljic
After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an unexpected reconnection.
Advocacy text.
June 19th 2025

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

Mindy Sue Cohen
Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.
Related Content
Advertisement
Image of women with text.
June 25th 2025

June Breast Cancer Highlights: Top 5 Updates Patients Should Know

Ryan Scott
June brought major breast cancer updates, and CURE is sharing the latest treatment combinations, biomarker-driven care and patient well-being.
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
February 12th 2024

Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Alex Biese Brielle Benyon
Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy: © stock.adobe.com.
June 24th 2025

How a Blood Test May Help Guide Breast Cancer Treatment

Ryan Scott
Dr. Rita Mukhtar sits down for a conversation with Dr. Joshua Sabari to discuss the potential use of ctDNA to guide breast cancer therapy.
FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment
February 5th 2024

FDA, Cancer Vaccine Updates and a Misguiding of Breast Cancer Treatment

Alex Biese Brielle Benyon
One cancer vaccine may still be years away from being available, a breast cancer test may be misguiding treatments for Black women and the review of two oncology regimens are being expedited by the FDA.
After my breast cancer diagnosis, faith guided me through fear: © stock.adobe.com.
June 23rd 2025

Faith, Friendship and Finding Purpose After Breast Cancer

Shirley Rakuljic
After my breast cancer diagnosis, faith guided me through fear, and in passing on a blessed bracelet, I found healing and an unexpected reconnection.
Advocacy text.
June 19th 2025

Self-Advocacy Can Help Patients Navigate Cancer Treatment Challenges

Mindy Sue Cohen
Speaking up during cancer treatment helped one patient manage side effects, address insurance issues and stay productive throughout chemotherapy.
About Us
Advertise / Support
Editorial Board
Contact Us
CancerNetwork.com
TargetedOnc.com
OncLive.com
OncNursingNews.com
Terms & Conditions
Privacy
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.